"ActivMed is a multi-specialty clinical research company comprised of 4 locations in northern Massachusetts and southern New Hampshire. We conduct studies in the areas of Neurology, Family Medicine, Psychiatry, Dermatology, Gastroenterology, Pain, Nutraceuticals, Vaccines, Medical Devices, and more."

During the past decade, ActivMed Practices & Research, Inc. conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 64 clinical trials were completed, i.e. on average, 63.4% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 39 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ActivMed Practices & Research, Inc." #1 sponsor was "Eli Lilly and Company" with 36 trials, followed by "Pfizer" with 15 trials sponsored, "Amgen" with 5 trials sponsored, "Biogen" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ActivMed Practices & Research, Inc." #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Athenex, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Nektar Therapeutics" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "ActivMed Practices & Research, Inc." are "Alzheimer's Disease" (13 trials), "Alzheimer Disease" (9 trials), "Atopic Dermatitis" (9 trials), "Psoriasis" (7 trials) and "Depressive Disorder, Major" (6 trials). Many other conditions were trialed in "ActivMed Practices & Research, Inc." in a lesser frequency.

Most popular intervention types in "ActivMed Practices & Research, Inc." are "Drug" (113 trials), "Biological" (14 trials), "Other" (14 trials), "Device" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (75 trials), "Tirzepatide" (5 trials), "Lebrikizumab" (4 trials), "Rapastinel" (4 trials) and "ASN002" (3 trials). Other intervention names were less common.

The vast majority of trials in "ActivMed Practices & Research, Inc." are 126 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "ActivMed Practices & Research, Inc.". undefined are not yet recruiting, 16 are recruiting, 14 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 74 completed trials in ActivMed Practices & Research, Inc., undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in ActivMed Practices & Research, Inc., 3 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".